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Abstract.  Chicken erythroblasts transformed with 
avian erythroblastosis virus or S13 virus provide suit- 
able model systems with which to analyze the matura- 
tion of immature erythroblasts into erythrocytes. The 
transformed cells are blocked in differentiation at 
around the colony-forming unit-erythroid stage of de- 
velopment but can be induced to differentiate in vitro. 
Analysis of the expression and assembly of compo- 
nents of the membrane skeleton indicates that these 
cells simultaneously synthesize t~-spectrin,  ~spectrin, 
ankyrin,  and protein 4.1  at levels that are comparable 
to those of mature erythroblasts.  However, they do not 
express any detectable amounts of anion transporter. 
The peripheral  membrane skeleton components assem- 
ble transiently  and are subsequently rapidly catabo- 
lized, resulting in 20-40-fold lower steady-state levels 
than are found in maturing erythrocytes. Upon sponta- 
neous or chemically induced terminal differentiation of 
these cells expression of the anion transporter is initi- 
ated with a concommitant increase in the steady-state 
levels of the peripheral membrane-skeletal compo- 
nents.  These results suggest that during  erythropoiesis, 
expression of the peripheral components of the mem- 
brane skeleton is initiated earlier than that of the anion 
transporter.  Furthermore,  they point a key role for the 
anion transporter in conferring long-term stability to 
the assembled erythroid membrane skeleton during 
terminal differentiation. 
RYTHROPOIESIS  in both mammalian  and avian species 
involves a sequence of events whereby a pluripotent 
stem cell becomes committed to the erythroid cell 
lineage and thence progresses through  at least two replica- 
tive progenitor stages,  known as burst-forming  unit-eryth- 
roid (BFU-E)  1 and colony-forming  unit-erythroid (CFU-E) 
stages,  before reaching  the distinctive  erythroblast  stages 
(reviewed in Metcalf and Moore, 1971; Till and McCulloch, 
1980).  The  BFU-E and  CFU-E cells have  thus  far  been 
identified solely in terms of (a) their progeny colony size and 
hence number of cell divisions from the terminally  differen- 
tiated erythroid state, (b) their responsiveness  to hemopoi- 
etic factors such as colony-stimulating  factor (interleukin-3) 
and erythropoietin, and (c) the presence of certain diagnostic 
surface antigens  (Gregory,  1976; Gregory and Eaves,  1978; 
Samarut and Nigon,  1976; Samarut et al., 1979; Samarut and 
Bouabdelli,  1980; Till and McCulloch,  1980; Goodman et 
al.,  1985). Part of the terminal  differentiation  program of 
these erythroid progenitor cells entails  the restructuring  of 
the plasma membrane including  the biogenesis of a mem- 
1.  Abbreviations used in  this paper:  AEV,  avian erythroblastosis virus; 
BFU-E, burst-forming unit-erythroid; CFU-E, colony-forming unit-eryth- 
roid; MEL,  murine erythroleukemia. 
brane skeleton,  a network of proteins underlying  and inter- 
acting  with  the  plasma  membrane  (Branton  et al.,  1981; 
Marchesi,  1985). The major component of this network is 
the heterodimeric protein spectrin,  which, in the presence of 
protein 4.1, interacts with high affinity with short oligomers 
of actin to form a dense anastomosing  network (Branton et 
al., 1981; Ungewickell et al., 1979; Pinder and Gratzer,  1983; 
Pinder et al.,  1984; Marchesi,  1985). Interaction  with the 
membrane is mediated through the binding of the 13-spectrin 
subunit  to ankyrin (Bennett  and  Stenbuck,  1979a; Luna et 
al., 1979; Calvert et al., 1980; Litman et al., 1980) which in 
turn binds to the cytoplasmic domain of the transmembrane 
anion transporter (Bennett and Stenbuck,  1979b, 1980; Har- 
greaves et al., 1980). In mammals,  glycophorin may provide 
additional  membrane-binding  sites  through  its  interaction 
with protein  4.1 (Anderson and Lovrien,  1984), but as yet 
an avian equivalent  of glycophorin has not been identified. 
Synchronized  cohorts  of proliferative  erythroblasts  or 
postmitotic  immature  erythrocytes can be readily isolated 
from chick embryos at a stage when they are actively  syn- 
thesizing and assembling  the constituent  polypeptides of the 
membrane  skeleton,  in  sufficient  numbers  to  enable bio- 
chemical analysis  of their mechanisms  of assembly (e.g., 
Weise and Chan,  1978; Blikstad et al.,  1983). Studies with 
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eage have indicated that at this stage of erythroid develop- 
ment all members of the erythroid membrane skeleton are 
expressed simultaneously and accumulate on a per-cell basis 
by stable assembly (Weise and Chan, 1978; Blikstad et al., 
1983;  Moon and Lazarides,  1984; Woods and Lazarides, 
1985;  Staufenbiel  and  Lazarides,  1986). Hitherto,  these 
studies have not addressed the issue of exactly when in de- 
velopment expression of the  components is  initiated and 
whether their expression begins coordinately or asynchro- 
nously. Such studies are hindered by the difficulties of identi- 
fying erythroid progenitor cells (rather than their daughter 
colonies) unambiguously and then of isolating them in ade- 
quate numbers for biochemical analysis. Avian erythroblas- 
tosis virus (AEV)- and S13-transformed erythroid progenitor 
ceils provide a model system for an alternative approach to 
investigate the mechanisms underlying initiation of the as- 
sembly of this membrane domain. 
AEVs  are replication-defective RNA viruses that cause 
acute erythroleukemia within 1-2 wk after infection. The 
target cells in chicken yolk sac and bone marrow appear to 
be erythroid progenitor cells at the BFU-E stage which then 
develop to the CFU-E stage before becoming transformed 
and arrested in development (Gazzolo et al., 1980a, b; Graf 
et al.,  1981; Samarut and Gazzolo,  1982). Transformation 
abolishes the requirement of these cells for erythropoietin 
for growth. The AEV ES4 strain is defective in gag and pol 
sequences which have been replaced by oncogenic erb se- 
quences of cellular origin, v-erb A and v-erb B (Lai et al., 
1979; Coffin et al., 1981; Vennstr6m and Bishop, 1982). The 
v-erb B gene encodes a transmembrane glycoprotein that has 
tyrosine protein kinase activity and that bears extensive ho- 
mology with the epidermal growth factor receptor (Hayman 
et al., 1983; Privalsky et al., 1984; Gilmore et al., 1985; Kris 
et al.,  1985; Yamamoto et al.,  1983). The v-erb  A  gene, 
which has  marked homology with the  estrogen  receptor 
(Green, G. L. et al.,  1986; Green, S. et al.,  1986), is ex- 
pressed  as  a  gag-erb  A  fusion  protein,  localized  in  the 
cytoplasm of the transformed cells (Hayman et al.,  1979; 
Bunte et al.,  1982). By itself, v-erb A has no transforming 
activity; rather it appears to potentiate v-erb B activity in ad- 
dition to reducing the growth requirements of transformed 
cells and blocking their capacity to differentiate (Graf and 
Beug, 1978; Grafet al., 1978; Frykberg et al., 1983; Graf and 
Beug,  1983). 
The $13 retrovirus represents a different type of erythro- 
leukemic virus to the AEV group of viruses. Its genome of 
8.5  kb  encodes  a  transformation-specific  glycoprotein, 
gp155, that is cleaved posttranslationaUy into an 85-kD and 
70-kD glycoprotein (Benedict et al., 1985; Beug et al., 1985; 
Hayman et al.,  1985). Although the gp70 polypeptide does 
not appear to bear much structural resemblance to v-erb B, 
it possesses protein tyrosine kinase activity and in this re- 
spect may be  functionally similar to  the v-erb oncogenic 
protein encoded by the AEV genome. The S13 virus also 
transforms cells at a pro-erythroblast stage,  inducing rapid 
proliferation in an erythropoietin-independent manner but, 
in contrast to AEV, S13 only partially blocks differentiation 
and does not eliminate the cells' requirement for complex 
growth media. 
We have found that AEV-transformed cells as well as S13- 
transformed  cells  express  peripheral  components  of the 
erythroid membrane skeleton,  namely ¢t- and 13-spectrin, 
ankyrin, and protein 4.1. However they do not appear to ex- 
press the anion transporter as determined by immunoblot- 
ting, biosynthetic labeling, and Northern analysis. Kinetic 
analysis has revealed that in AEV-transformed cells, these 
peripheral components of  the membrane skeleton are synthe- 
sized in a short labeling period at levels equivalent to the lev- 
els found in proliferative primitive erythroid cells.  These 
proteins  inefficiently assemble  into a  membrane skeleton 
which is then turned over. In contrast, no detectable turnover 
of newly synthesized assembled protein occurs in maturing 
primitive erythroblasts. Initiation of spontaneous or chemi- 
cally induced terminal differentiation of transformed cells is 
associated with induction of expression of the anion trans- 
porter; this is paralleled by an increase in the steady-state 
levels of the peripheral components of the membrane skele- 
ton. These results indicate that expression of the peripheral 
components and  the  anion transporter  are  independently 
regulated during erythroid development; initiation of the ex- 
pression of the peripheral components occurs early in devel- 
opment (by the CFU-E stage)  while the expression of the 
anion transporter is intimately coupled with terminal differ- 
entiation. Furthermore, the extent of accumulation of the pe- 
ripheral skeletal components that occurs during erythroid 
terminal differentiation is regulated by an increase in the sta- 
bility of  the assembled polypeptides rather than by their tran- 
scriptional up regulation. The results point to a key role for 
the anion transporter in conferring long-term stability to the 
erythroid  membrane  skeleton  during  terminal  differenti- 
ation. 
Materials and Methods 
Viruses and Cells 
The sources of avian erythroblastosis virus strain ES4 and of virus S13 have 
been described (Lai et al., 1979; Beug et al.,  1985;  Benedict et al.,  1985). 
Single cell suspensions were prepared by mincing the yolk sacs of 7-d-old 
chicken embryos and filtering the minced tissue through a  narrow mesh, 
stainless steel screen. The cells were centrifuged at 1,000 rpm for 10 min 
and then suspended in fresh growth medium at a concentration of ~2  × 
10  s cells/nil. For infection with AEV, growth medium consisted of medi- 
um F10 and l0 mM Hepes, pH 7.3, 5  x  10  -5 M thioglycerol, and 9% FCS, 
8% chicken serum, and 3% NaHCO3 (0.33 M). For infection with S13, the 
growth medium consisted of medium FI0 containing 10 mM Hepes, pH 7.3, 
8  x  10  -5 M  mercaptoethanol, 3%  NaHCO3 (0.33  M),  8%  each of fetal 
calf and chicken serum, 0.08 % bovine serum albumin, and 5 % water. AEV 
infection was at a multiplicity of 0.1 for 2 h at 37°C. The AEV-infected cells 
were then suspended in semi-solid medium consisting of medium F10 with 
10 mM Hepes, pH 7.3, 5  x  10  -5 thioglycerol, 2% NaHCO3 (0.33 M), 8% 
FCS, 5% chicken serum, 5%  H20, and 0.9%  methocellulose. 
Infection with S13 either followed the protocol described above for AEV 
or was accomplished by seeding the yolk sac cells overnight onto a layer 
of S13-transformed, x-irradiam:l chicken embryo fibroblasts. Suspension of 
S13-infected yolk sac cells was in a medium consisting of medium F10 with 
10 mM Hepes, pH 7.3,  8  x  10  -5 M  mercaptoethanol, 2%  NaHCO3 (0.33 
M), 8% each of FCS and chicken serum, 0.8% BSA, 5%  H20, and 0.6% 
methocellulose. 
Colonies of transformed cells were picked  14-21  d  after infection and 
were initially plated in the liquid growth media described above. After a 
given colony had reached cell numbers above 107 , culture continued with 
the same liquid growth media except that F10 was replaced by DME. These 
cells were found to grow best at densities not exceeding 1 x  106, so conse- 
quently they were subcultured generally every third day and invariably the 
day before an experiment. Under these conditions several clones were found 
to grow up to 4 mo with a doubling time of ~24 h. For induction experi- 
ments, AEV-transformed cells were transferred to the CFU-E medium de- 
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erythropoietin (Amgen, Thousand Oaks,  CA). 
Mitotic  primitive erythroblasts were  isolated  from 3.5-4-d chick em- 
bryos by carefully excising the embryo and surrounding blood islands from 
the egg, teasing them apart and letting them bleed into MEM supplemented 
with 2 % FCS. The cells were passed through several layers of cheesecloth 
and then through cotton wool before washing three times in MEM, 2 % FCS. 
The cells were then incubated for 30 min in methionine-free medium before 
labeling experiments. 
Labeling Experiments 
AEV cells were washed three times in methionine-free DME before  sus- 
pending in labeling medium (methionine-free DME,  10% dialyzed FCS, 5 
×  10  -5 M thioglycerol)  to preincubate for 20 rain at 37.5°C in a humidified 
atmosphere containing 5%  CO2. For pulse-chase  experiments,  7  ×  107 
cells were  suspended  in 5  ml of labeling medium containing 600  ~Ci 
[35S]methionine and incubated for 8 rain before  pelleting the cells (total 
labeling time 10 min). Cells were resuspended in normal growth  medium 
containing 2  mM unlabeled methionine and divided into aliquots  of 107 
cells for further incubation. The aliquots of cells were sampled at appropri- 
ate intervals of chase time and added to excess ice-cold medium for process- 
ing.  For continuous pulse experiments aliquots  of cells were labeled with 
200  ~tCi[35S]methionine at a  starting  density of 106 cells/ml in labeling 
medium supplemented with 2 ~tM methionine in order to prevent methio- 
nine deprivation.  The cells were lysed sequentially  in identical volumes of 
hypotonic (10 mM Tris-HCl, pH 7.4, 5 mM MgC12, 2 mM EGTA, 2 mM 
phenylmethylsulfonyl  fluoride [PMSF], and 1 mM aprotinin) and 0.5% Tri- 
ton X-100 lysis buffer (130 mM NaCI,  10 mM Tris-HC1,  5 mM MgCI2, 
2 mM EGTA, 0.5%  Triton X-100, 2 mM PMSE  1 mM aprotinin), taking 
care to resuspend ghosts with a minimum of agitation.  The final pellet was 
resuspended in an equal volume of hypotonic  buffer. All these operations 
were carried out at 4°C.  This yielded an operationally defined cytoplasmic 
(hypotonic  lysate),  noncross-linked membrane-associated (Triton  lysate) 
and insoluble (cytoskeletal plus nuclear)  fraction respectively, as described 
previously  (Woods and Lazarides,  1985). Samples were denatured by addi- 
tion of 1/$ vol 5% SDS, 5 mM EGTA,  10 mM Tris-HCI, pH 7.4,  2 mM 
I~-mercaptoethanol followed by sonication for the insoluble fractions. 
Each lysate  for each time point was divided into equal  aliquots,  pre- 
cleared with preimmune serum before  immunoprecipitation with anti-et- 
spectrin (Repasky  et al.,  1982),  anti-l]-spectrin (Nelson and Lazarides, 
1984), anti-ankyrin (Nelson and Lazarides,  1984), anti-protein 4.1 (Granger 
and Lazarides,  1984a) and anti-anion  transporter (Cox et al., 1985) specific 
antibodies.  Immunoprecipitation,  autoradiography,  and quantitation of la- 
beled protein was carried out as described previously  (Woods and Laza- 
rides,  1985). 
Immunoblotting 
Cells were washed twice in DME and then solubilized either directly in SDS 
sample buffer or after making hypotonic,  0.5% Triton X-100 and insoluble 
fractions to give the equivalent of 106 cells per 25 I~1 of final SDS sample. 
Samples were subjected to 7.5% SDS PAGE and transferred to nitrocellu- 
lose.  Filters were probed with one of the antibodies mentioned above or 
anti-vimentin  (Granger  and l.ztzarides, 1982) at a dilution of 1:1,000, washed 
and probed with U~l-protein A (Granger and Lazarides,  1984a). After ex- 
posure to Kodak XAR-5 film,  labeled bands were cut out and counted on 
a gamma counter.  Quantitative  results were ensured by using cell loadings 
Figure 1. AEV- and S13-trans- 
formed erythroid cells express 
the peripheral components of 
the  membrane  skeleton  but 
not the anion transporter. Im- 
munoblots of 3  x  105 mature 
chicken  erythrocyte  ghosts 
(lanes 1 ) or the Triton X-100- 
insoluble  (lanes  2)  and  -sol- 
uble  (lanes 3)  fractions from 
3  x  106 AEV-cells (A) or S13 
cells  (B).  Ank,  ankyrin; aS, 
a-spectrin;  /IS,  ~spectrin; 
4.1,  protein  4.1;  AT,  anion 
transporter.  Antigens  desig- 
nated by dots. The differences 
in the relative amounts of the 
4.1  variants between Fig.  1 A 
(AEV) and  1 B  (S13)  are due 
to  differences  in  exposure 
time. 
Woods et al. Control of Etythroid Differentiation  1791 within the range that gave linear increases in signal (1-6  ×  10  s cells/lane) 
and by reducing the number of mature chick erythrocyte ceils loaded as stan- 
dard to give a signal close to that obtained with transformed cells. 
RNA Isolation and Analysis 
Cytoplasmic RNA was isolated using the phenol method described in Moon 
et al.  (1985)  from either 109 erythroblasts from 9-d embryos or 5  ×  108 
AEV-transformed cells.  Poly(A)  ÷ RNA was purified through oligo-(dT) 
cellulose according to the method of Aviv and I.e,  der 0972). Northern analy- 
sis was performed as described by Ngai et al. (1984).  Essentially RNA was 
separated on a  1.2%  agarose gel containing 6%  formaldehyde and trans- 
ferred to nitrocellulose for 10 h before being baked. Subsequently one set 
of lanes was probed with a  vimentin-specific 32p-labeled  probe  (Ngai et 
al.,  1984)  and the duplicate set of lanes was probed with a  32p-labeled 
probe specific for anion transporter transcripts (Cox et al.,  1985). 
Results 
Expression of  Peripheral Components of the Erythroid 
Membrane Skeleton in AEV- and S13-transformed Cells 
Steady-state protein analysis carried out by immunoblotting 
revealed  that  AEV-transformed  cells  express  ct-spectrin, 
~-spectrin, ankyrin, and protein 4.1 (Fig. 1 A). A similar re- 
sult is also observed with S13-transformed cells (Fig.  1 B). 
Quantitation of irnmunoblots of AEV cell extracts showed 
that the steady-state levels of a-spectrin, ~spectrin, ankyrin, 
and protein 4.1 were '~1/5, 1/24, 1/29, and ~1/50, respectively, 
of the levels found in mature erythrocytes (Table I). These 
translate to ratios of 13-spectrin to ankyrin to protein 4.1 of 
,'~1:0.5:0.5  (Table I) which is similar to the ratios of these 
proteins found in mitotic primitive erythroblasts (Staufenbiel 
and Lazarides,  1985).  Similar values were found with S13- 
transformed erythroid cells except that these cells appeared 
to express even lower levels of ankyrin that translated to a 
13-spectrin/ankyrin  ratio of ~4:1 (Table I). The ratio of 5:1 
found for a-spectrin to [3-spectrin  in both types of trans- 
formed cells exceeds the 1:1 stoichiometry observed in de- 
veloping and mature erythrocytes; this we presume to reflect 
the concurrent expression of a non-erythroid form of spec- 
trin, a't-spectrin, but in the absence of a probe for 7-spectrin 
we could not verify this. Fifteen different AEV-transformed 
clones were analyzed to check the degree of variation exist- 
ing between different transformed cell lines. All gave identi- 
cal quantitative and qualitative steady-state patterns of these 
proteins (data not shown). 
Both the AEV and $13 cells express a similar pattern of 
variants of protein 4.1, the 155-, 145-, 87-, and 77-kD variants 
although the upper variants appear to be the more dominant 
ones in S13-transformed cells (Fig.  I). This pattern differs 
from the pattern of variants seen in postmitotic erythrocytes; 
rather they appear to bear a  greater similarity to the pat- 
tern observed in proliferative primitive or definitive cells 
(Granger and Lazarides, 1984b;  Staufenbiel and Lazarides, 
1986) except that in these latter cells the 77-kD variant is 
more abundant. The same two variants of ~-spectrin that ex- 
ist in immature and mature chick erythrocytes are seen in 
both types of transformed cells, a major variant of apparent 
Mr  220,000  and  a  minor variant with  an  apparent Mr  of 
~225,000. Likewise the pattern of ankyrin variants observed 
in transformed cells is similar to the pattern observed in ma- 
ture chick erythrocytes (Fig.  1). 
a-Spectrin [3-Spectrin, Ankyrin, and Protein 4.1 
Are Associated with the Plasma Membrane 
of Transformed Cells 
To establish where the spectrins, ankyrin, and protein 4.1 
were localized in transformed cells, we carried out indirect 
immunofluorescence. All of  these proteins appeared to local- 
ize at the plasma membrane (data not shown). To examine 
their localization further, we analyzed their solubility prop- 
erties. With both types of transformed cells, these proteins 
cannot be detected at steady state in the hypotonic lysate; 
rather they appear to be partitioned between a Triton-soluble 
and cytoskeletal  pool, with similar ratios of  the four polypep- 
tides within each pool (Table I). When developing and ma- 
ture erythrocytes are lysed in hypotonic or Triton X-100-con- 
taining buffers the spectrins, ankyrin, and protein 4.1 remain 
quantitatively insoluble at steady state. This is a consequence 
of their being cross-linked into a skeletal array (Yu et al., 
1973; Woods and Lazarides,  1985;  Staufenbiel and  Laza- 
rides,  1986).  Therefore, the  solubility properties of these 
proteins in transformed cells are consistent with the interpre- 
tation  that  these proteins  are  associated  with  the plasma 
membrane but suggest that they are inefficiently cross-linked 
into a cytoskeleton. No difference in the patterns of 13-spec- 
trin and protein 4.1  variants are seen between the Triton- 
soluble  and  -insoluble pools  (Fig.  1).  Ankyrin,  however, 
shows the typical erythrocyte  pattern in the insoluble fraction 
Table L Steady-state  Ratios of  the Peripheral Components 
of  the Membrane Skeleton in Transformed  Erythroid Cells 
Adult  Steady-state ratio 
Erythrocyte/  of antigen to 
Protein  AEV  INSOL/TX  13-spectrin 
AEV-transformed erythroid cells 
a-Spectrin  5.2  +  0.6  1.9  4.66  +  0.24 
13-Spectrin  23.3 + 2.8  4.5  1.0 
Ankyrin  29.0 + 3.2  2.4  0.49 + 0.07 
Protein 4.1  51.1  +  8.2  1.2  0.44 + 0.09 
Anion transporter  ND  -  - 
Vimentin  5.0 + 0.8  -  - 
S13-transformed erythroid cells 
a-Spectrin  4.1 
13-Spectrin  21.6 
Ankyrin  50.8 
Protein 4.1  39.4 
Anion transporter  ND 
Vimentin  3.6 
Induced AEV cells 
a-Spectrin  4.2 
13-Spectrin  13.1 
Ankyrin  16.7 
Protein 4.1  26.5 
Anion transporter  10.8 
1.2  5.2 
2.2  1.0 
2.1  0.22 
1.0  0.55 
3.2 
1.0 
0.4 
0.5 
1.2 
Labeled bands from immunoblots such as the ones shown in Fig.  1 were cut 
out and counted in a gamma counter. Then the following parameters were cal- 
culated:  the steady-state ratio of each antigen in a population of transformed 
erythroid cells compared to mature chick erythrocytes; the steady-state ratio 
between  the  Triton-soluble  (TX)  and  -insoluble  (INSOL)  fractions  from 
transformed cells; and the steady-state ratio of each antigen with respect to 
I~-spectrin existing in transformed cells. The data for AEV-transformed eryth- 
roid cells represent the mean of five  experiments +SE.  The data for S13- 
transformed erythroid cells and induced AEV ceils represent the mean result 
of two experiments. The data for the induced cells represent the average data 
for a population of 3  ×  106 AEV cells out of which 24% are strongly positive 
for hemoglobin and 23%  are weakly positive. 
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Nelson  and  Lazarides,  1984)  is  replaced by a  variant of 
slightly higher apparent molecular weight (Fig. 1). However, 
since the apparent M, of chicken ankyrin differs on different 
percentage SDS PAGE (data not shown), it is unclear at pres- 
ent what the differences in apparent Mr might signify. This 
awaits  further investigation. 
The Lower Steady-state Levels of Spectrin, Ankyrin, 
and Protein 4.1 in AEV-transformed CeUs As 
Compared with Erythrocytes Are Due to Different 
Rates of  Catabolism 
The lower steady-state levels of the peripheral components 
of the erythroid membrane skeleton observed in transformed 
cells as compared to mature erythrocytes could arise from 
lower rates of synthesis, different rates of catabolism, or a 
combination of the two. Short-term pulse labeling (10 min) 
was used to compare the amounts of labeled peripheral poly- 
peptides  synthesized  in  identical  numbers  of AEV-trans- 
formed cells, mitotic erythroblasts from 3.5--4-d  embryos, 
and postmitotic immature erythrocytes from 10 and 14 d em- 
bryos (stages when these proteins are accumulating in the 
membrane skeleton on a per-cell basis (Blikstad et al., 1982; 
Moon and Lazarides,  1984;  Woods and Lazarides,  1985). 
Surprisingly, the AEV cells synthesized these proteins on a 
per-cell per-unit time basis, at amounts that were equivalent 
to the amounts synthesized by mitotic erythroblasts and that 
were close to 10-fold greater than the amounts synthesized 
during  a  10-min  labeling  period  in  postmitotic  immature 
erythrocytes (Table II). Therefore, the low steady-state levels 
of these peripheral components in transformed cells com- 
pared to erythrocytes could not be accounted for by low rates 
of synthesis. 
Kinetic pulse chase analysis revealed that in AEV cells, a 
portion of newly synthesized t~-spectrin, 13-spectrin,, anky- 
rin,  and protein 4.1  polypeptides entered a Triton-soluble 
compartment and a portion became Triton-insoluble, i.e., 
cytoskeletal (Fig. 2). The excess hypotonic pools rapidly dis- 
appeared. The Triton-soluble pools of all of these proteins 
turned over in an apparently biphasic manner with an initial 
t,4 of 45-60 min. Only a small portion of this loss could be 
accounted for by transfer into the insoluble pool. Thus it ap- 
pears that most of the decline in this pool was due to rapid 
degradation. The insoluble pools also turned over, although 
with a  slightly longer t,/, than the Triton-soluble pools. In- 
Table II. The Relative Amounts of  Labeled a-Spectrin, 
fl-Spectrin,  and Ankyrin Synthesized during a l O-min 
Labeling Period 
Relative amounts of the peripheral 
polypeptides synthesized 
Erythroblasts from  Erythroid cells from 
Protein  AEV cells  3-4-d embryos  10-d embryos 
a-Spectrin  10.6  12.9  1 
13-Spectrin  9.4  10.1  1 
Ankyrin  4.7  10.4  1 
3  x  106 cells were labeled  for 10 min with [3~S]methionine  and the amounts 
of labeled spectrins and ankyrin synthesized during this period were quantitat- 
ed  by  immunoprecipitation followed  by  autoradiography.  The data  are ex- 
pressed as amounts synthesized relative to the amounts synthesized in erythroid 
cells from 10-d embryos. 
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Figure 2. Kinetic analysis of the fate of newly synthesized polypep- 
tides in AEV-transformed cells. AEV cells were pulsed for 10 min 
with [3~S]methionine  and then divided into seven aliquots that were 
chased in a medium containing excess unlabeled methionine for up 
to 12 h. The aliquots of cells were fractionated into a hypotonically 
soluble (open triangle), Triton X-100-soluble (X) and -insoluble 
(solid circle) fraction. The labeled a-spectrin,  ~spectrin, ankyrin, 
and protein 4.1  were quantitated as described  in Materials and 
Methods; values are expressed as the logarithm of relative peak 
areas and represent the mean value from four experiments. The data 
have not been corrected for any increase in cell numbers that oc- 
curred due to cell division during the chase period; rather they re- 
flect the fate of the labeled polypeptides. 
soluble a-spectrin had a longer t,~ than the other polypep- 
tides of ,o8  h  whereas insoluble 13-spectrin,  ankyrin,  and 
protein 4.1  (all variants behaved in an identical fashion) all 
turned over with a t,~ of ,o4.5 h (Fig. 2). Continuous pulse- 
labeling experiments indicated that the insoluble pools pla- 
teau around 4 h which confirms the fairly rapid turnover of 
these assembled proteins in AEV-transformed cells (data not 
shown). It should be noted that these half lives are consider- 
ably shorter than the doubling time (22-24 h) for these cells, 
so it seems unlikely that this instability could be linked to the 
fact that these cells are proliferating during this period of 
chase time. To distinguish between the possibility that the in- 
stability of  the assembled pools of  the spectrins, ankyrin, and 
protein 4.1 might be a consequence of the cells being a popu- 
lation of proliferative cells rather than being a feature unique 
to these cells and the stage of erythroid development that they 
represent, the fate of newly synthesized proteins in mitotic 
primitive  erythroblasts  from  3.5-4-d  chick  embryos  was 
compared. Erythroblasts at this stage have been reported to 
have a doubling time of 17.5 h (Weintraub et al.,  1971), i.e., 
similar to the doubling time of AEV-transformed erythroid 
cells. As seen in Fig.  3, the assembled pools in these cells 
appeared to be stable with no evidence of turnover during the 
chase time monitored (8 h). 
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Figure 3. Kinetic analysis of the fate of newly synthesized polypep- 
tides in mitotic primitive erythroblasts from 3-4-d chick embryos. 
Cells were pulse-labeled and fractionated exactly as described for 
AEV cells. The amounts of labeled ¢t-spectrin, ffspectrin, ankyrin, 
and the anion transporter in the hypotonically soluble (open trian- 
gle), Triton-soluble (X) and -insoluble (solid circle) fraction as a 
function of chase time are expressed in logarithmic form. 
AEV- and S13-transformed Erythroblasts Do Not 
Express Anion Transporter 
In contrast to the peripheral components of the membrane 
skeleton,  immunoblotting with anti-anion transporter-spe- 
cific antibodies failed to detect the presence of anion trans- 
porter in either AEV- or S13-transformed erythroid precur- 
sor cells. Using serial dilutions of the erythrocyte standard, 
we calculated that we should have been able to detect down 
to 1/125 the levels of anion transporter found in erythrocyte 
membrane skeletons. Since the stoichiometry of the different 
components in the mature membrane skeleton is known, it 
is possible to use the erythrocyte standard to calculate the 
stoichiometry that exists in the AEV-transformed cells. As 
shown in Table I, the ct-spectrin/13-spectrin/ankyrin/protein 
4.1 ratio is '~5:1:0.5:0.5 in AEV cells with similar values for 
undifferentiated S13 cells. In the mature erythrocyte mem- 
brane skeleton, the ratio of ankyrin to anion transporter is 
1:1 with the skeletal-bound anion transporter accounting for 
only 1/6 the total amount of anion transporter (Bennett and 
Stenbuck,  19"/9b; Hargreaves et al.,  1980;  Branton et al., 
1981; Nelson and Lazarides,  1984).  Therefore, even if the 
transformed cells do contain trace levels of anion transporter, 
it is far below the levels relative to other skeletal components 
seen in erythrocytes and developing erythroid cells (see Fig. 
3). Labeling experiments failed to detect the synthesis of the 
anion  transporter  in  AEV-transformed cells.  In  contrast, 
proliferative erythroblasts synthesized high levels of anion 
transporter (Fig. 3). Although a large portion of the Triton- 
soluble pool turned over, a  fraction of mature anion trans- 
porter assembled into the skeletal fraction in a stable manner. 
Northern analysis corroborated the lack of synthesis of anion 
transporter in AEV-transformed cells.  As demonstrated in 
Fig. 4 an anion transporter-specific cDNA probe (Cox et al., 
1985) failed to detect the presence of any anion transporter 
transcripts  in  cytoplasmic mRNA  from AEV-transformed 
cells. In contrast a vimentin-specific cDNA probe detected 
vimentin-specific  transcripts  in  the  RNA  from  AEV- 
transformed erythroid cells (as a control, data not shown). 
AEV and $13 Cells Express Anion Transporter upon 
Spontaneous or Chemically Induced Differentiation 
AEV-infected erythroid progenitor cells have a finite growth 
potential, generally extending over 3--4 mo. Thereafter, the 
cells appear to initiate differentiation spontaneously and then 
die. A similar sequence of events can be induced chemically 
by the addition of butyrate (1  mM) to the culture medium 
supplemented  with  1  U/ml  erythropoietin (Keane  et  al., 
1979). Unlike murine erythroleukemia cells, AEV cells do 
not respond to DMSO (Keane et al.,  1979; Graf and Beug, 
1982).  Initiation of differentiation, whether spontaneous or 
chemically induced, was associated with the appearance of 
the anion transporter "-3 d after induction as detected by im- 
munoblotting  (Fig.  5)  or  immunofluorescence  (data  not 
shown). This was coupled with increased steady-state levels 
of 13-spectrin, ankyrin, and protein 4.1 as judged by immuno- 
blotting  analysis  (Table I).  Before induction,  <1%  of the 
AEV-transformed cells  stained  for hemoglobin with  acid 
benzidine (Orkin et al.,  1975). After 2 d in 1 mM butyrate, 
~10 % of the ceils stained positively with benzidine and after 
3 d 24 % stained strongly positive and 23 % stained weakly 
positive for hemoglobin.  The strongly positive cells were 
quite distinct in shape from the negative cells, being gener- 
ally smaller in size and more elliptical in shape. A few pos- 
sessed  spikelet protruberances.  The weakly  positive cells 
were similar in shape to the avian reticulocytes described by 
Beug  et al.  (1982a,  b).  The same  shaped  cells that  were 
strongly positive for hemoglobin were  positive for anion 
transporter by immunofluorescence (data not shown). 
Discussion 
Understanding the mechanisms underlying differentiation, 
whereby the orderly activation or suppression in the expres- 
sion of genes in response to environmental signals leads to 
Figure 4.  Northern analysis of cytoplas- 
mic RNA from AEV cells compared with 
erythroblasts  from  9-d  chick  embryos. 
Autoradiogram of a blot containing 1 10g 
of poly(A)  ÷ RNA  from  chick  erythro- 
blasts (lane 1 ) and 10 gg total cytoplasmic 
RNA from AEV cells (lane 2) that was hy- 
bridized to a 32P-labeled anion transport- 
er cDNA probe. 
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porter upon induction of differentiation. 
Immunoblots of Triton-soluble (lane 1) 
and -insoluble fractions (lane 2) from 3 × 
106 AEV cells after  spontaneous initia- 
tion of differentiation. 3  x  106 mature 
chick erythrocyte ghosts (lane 3). 
cellular diversity remains a crucial issue in biology. Eryth- 
ropoiesis is initiated as the replicative progeny of pluripotent 
stem cells becomes restricted in its developmental potential 
and committed to the erythroid lineage. After a minimum of 
two  replicative  stages,  BFU-E  and  CFU-E,  where  the 
erythroid progenitor cells become increasingly more respon- 
sive to erythropoietic inducers, the cells begin to differentiate 
terminally as evidenced by the appearance of hemoglobin 
(Metcalf  and  Moore,  1971; Till  and  McCulloch,  1980; 
Weiss, 1984). Unlike other cell lineages, e.g., muscle, where 
terminal differentiation is initiated as the cells become post- 
mitotic, in erythroid cells terminal differentiation as defined 
by the appearance of hemoglobin, is initiated while erythro- 
blasts are still mitotic. These cells undergo a finite number 
of cell divisions which are accompanied by a  sequence of 
maturation  steps  leading to  postmitosis  and  the  ultimate 
erythrocyte phenotype (Till  and McCulloch,  1980; Weiss, 
1984). In avian species part of this maturation process entails 
the elaboration of three interlinked skeletal domains that are 
responsible for the morphology of the mature erythrocyte; 
a  spectrin-actin based membrane skeleton (this domain is 
common to both avian and mammalian erythrocytes) (Bran- 
ton et al., 1981; Lazarides, 1985; Marchesi, 1985); a system 
of vimentin-based intermediate filaments that appear to in- 
terlink the nucleus with the plasma membrane (Harris and 
Brown,  1971; Haggis and Bond,  1979; Granger and Laza- 
rides, 1982), and a marginal band of microtubules, laterally 
disposed to the intermediate filament network (Benhke,  1970; 
Swan and Solomon, 1984; Murphy et al., 1986). The elabo- 
ration of one of these domains, the intermediate filament net- 
work has been shown to occur as the erythroid cells become 
postmitotic (Capetanaki et al., 1983). Basal levels of vimen- 
tin mRNA and vimentin filaments are present throughout the 
mitotic maturation phase of erythroblasts but they are aug- 
mented when the cells become postmitotic. The timing of the 
initiation of expression and the control of assembly of the 
components of the membrane skeleton during the various 
phases of erythroid terminal differentiation are less well es- 
tablished. 
Studies  with early proliferative or postmitotic  erythro- 
blasts of both the primitive and definitive lineage from chick 
embryos have revealed that these cells are expressing and as- 
sembling all the major components of the membrane skele- 
ton  simultaneously (e.g.,  a-spectrin,  13-spectrin, ankyrin, 
anion transporter, and protein 4.1) (Chan,  1977; Weise and 
Chan,  1978; Blikstad et  al.,  1983; Moon  and  Lazarides, 
1984; Woods and Lazarides,  1985; Staufenbiel and Laza- 
rides, 1986). The first indication of asynchrony in the expres- 
sion of these proteins appears late in terminal differentiation 
in the case of protein 4.1 whose synthesis is maintained be- 
yond that of the other components during the final matura- 
tion stages  of postmitotic primitive and definitive erythro- 
cytes (Staufenbiel and Lazarides, 1986). The situation with 
mammalian reticulocytes is less clear.  In vivo labeling of 
mice and anemic rabbits  indicates that synthesis of mem- 
brane skeletal components occurs late in development before 
the reticulocyte stage but an asynchrony in the termination 
of synthesis is also observed. In one case, synthesis of band 
three (anion transporter) continued beyond that of the pe- 
ripheral components (Chang et al.,  1976), whereas  in an- 
other case the synthesis of the spectrins, ankyrin, and band 
three terminated simultaneously with the synthesis of band 
4 and 5 (actin) continuing into the reticulocyte stage (Koch 
et  al.,  1975). Circulating reticulocytes in anemic  sph/sph 
mice which carry a lesion in tl-spectrin (Bodine et al., 1984), 
have been shown to synthesize all the other major compo- 
nents of the membrane skeleton. These studies suggest that 
the expression and assembly of the membrane skeleton is a 
late event of the erythropoietic pathway but do not address 
the issue of at what stage of erythropoiesis these proteins be- 
gin to be expressed or whether there is any asynchrony in the 
initiation of expression of the different components. Friend 
murine  erythroleukemia (MEL)  cells  have  provided  one 
model  system  to  study  this  issue  since  they  represent 
erythroid cells that are transformed at an early proerythro- 
blast stage but can be induced chemically to undergo termi- 
nal differentiation. Before induction, MEL cells express only 
the more generalized form of spectrin, namely ct~,-spectrin 
and  very  low  levels  of  erythroid-specific  spectrin,  ct~ 
spectrin, but once chemically induced to initiate differentia- 
tion, the cells begin to express elevated levels of erythroid 
spectrin (Eisen et al.,  1977; Glenney and Glenney, 1984), 
band three (Sabban et al.,  1982), and glycophorin (Ikawa et 
al., 1973) concommitantly with hemaglobin, thus suggesting 
that synthesis of at least these membrane skeletal compo- 
nents  begins  simultaneously  upon  initiation  of  terminal 
differentiation. However, MEL cells induced to differentiate 
in vitro differ from normal erythroid progenitor cells in be- 
ing erythropoietin independent. Furthermore, they do not go 
through the normal sequence of erythroblast stages  (Marks 
and  Rifldnd,  1978). Therefore,  it  is  unclear how  closely 
events observed in this model system mimic normal erythro- 
poiesis. 
Chicken erythroid progenitor cells transformed with the 
avian erythroblastosis and S13 viruses differ in these regards 
since when induced to differentiate they do so in an eryth- 
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criteria, to fully differentiated erythrocytes through the nor- 
mal early erythroblast and polychromatophilic erythroblast 
(the avian equivalent of reticulocyte) stages (Graf and Beug, 
1978; Graf et al., 1978; Beug et al., 1982a, b). Furthermore, 
the evidence suggests that AEV ceils are transformed cells 
that are blocked in their differentiation  pathway at the CFU-E 
stage rather than being cells that have somehow dedifferenti- 
ated as a  consequence of transformation (Graf and Beug, 
1978; Gazzolo et al., 1980a, b; Samarut and Gazzolo, 1982). 
Previous studies have failed to detect the presence of spec- 
trin by immunofluorescence in AEV-transformed erythro- 
blasts (Beug and Hayman, 1984). The observations reported 
here indicate that not only do AEV-  and  S13-transformed 
cells express ct-spectrin but also erythroid-specific periph- 
eral components, namely ~spectrin,  ankyrin, and protein 
4.1.  However, they do not appear to express anion trans- 
porter, the protein that is thought to serve as one of the major 
transmembrane receptors for the erythroid skeleton.  This 
lack of anion transporter protein at steady state appears to be 
regulated at the level of mRNA as evidenced by the lack of 
synthesis of this protein and the lack of any detectable anion 
transporter mRNA.  At  steady  state,  both types of trans- 
formed cells contain greatly reduced levels of ct-spectrin, 
13-spectrin, ankyrin,  and protein 4.1  than found in mature 
erythrocyte membrane skeletons. Although the ratios of eryth- 
roid-specific components found in both AEV- and S13-trans- 
formed cells are similar to the ratios found in proliferative 
erythroblasts (Staufenbiel and Lazarides, 1986), the ratio of 
ct-spectrin to 13-spectrin is 5:1,  which differs from the  1:1 
stoichiometry seen in developing and mature erythrocytes. 
This we presume to reflect the concurrent expression of a~- 
and  ctl3-spectrin,  a  situation that is  analogous  to that ob- 
served in MEL cells (Glenney and Glenney, 1984). If this is 
indeed the case, then it would explain the slower rate of turn- 
over of the insoluble ct-spectrin observed in the transformed 
cells compared to the erythroid-specific components, since 
the  turnover  rate  would  reflect the  average  value  of two 
et-spectrin-containing pools.  Unlike mammals,  avian spe- 
cies possess a single copy gene for ct-spectrin (Moon et al., 
1985) and the same gene product is found in both erythroid 
(~t13) and  nonerythroid (a~')  spectrin.  In the absence of a 
probe for ~/-spectrin we were unable to distinguish between 
the two ¢t-spectrin-containing forms. 
The induction of expression of proteins that are character- 
istic of a terminally differentiated cell lineage is typically not 
an absolute one; rather a low level of expression is seen be- 
fore terminal differentiation but this is augmented after ini- 
tiation of terminal differentiation leading to an increase in 
their steady-state levels. For example, this is seen in the case 
for globin (Marks  and Rifkind,  1978; Keane et al.,  1979; 
Weintraub et al.,  1982)  and  vimentin  (Capetanaki  et al., 
1983) in developing erythroblasts. Therefore an obvious ex- 
planation of the much lower steady-state levels of the periph- 
eral membrane skeletal components in AEV- and S13-trans- 
formed cells would be a lower expression of these proteins 
compared to maturing erythroblasts. Surprisingly, this was 
found not to be the case. Their levels of synthesis in AEV 
cells were equivalent to the levels observed in early prolifer- 
ative primitive erythroblasts.  They were also  several-fold 
higher than the levels observed in postmitotic immature eryth- 
rocytes at the stage where the membrane skeletal compo- 
nents are accumulating and the steady-state levels are 20- 
50-fold  higher.  However,  unlike  proliferative  primitive 
erythroblasts, AEV cells exhibited a high rate of turnover of 
assembled ~t-spectrin, 13-spectrin, ankyrin, and protein 4.1. 
Thus it appears that the low steady-state levels of these poly- 
peptides in these cells compared to erythroblasts are due to 
differences in rates of catabolism rather than differences in 
rates of synthesis. The fact that these molecules appear to as- 
semble in a stable fashion in proliferative primitive erythro- 
blasts  isolated  from 3-4-d  embryos which  have been  re- 
ported to have a doubling time of 17.5 h (Weintraub et al., 
1971) which  is  similar  to  the  generation  time  of  AEV- 
transformed erythroid cells (22-24 h) eliminated the possi- 
bility that this marked difference in stability was due to the 
fact that AEV cells are actively proliferating. Rather, this in- 
stability appears to be a  unique feature of the AEV-trans- 
formed cells  and  the  stage of development that they rep- 
resent. 
AEV transformation of erythroid progenitor cells is finite, 
generally lasting between 40 and 60 generation times before 
the cells lose their transformed character, begin to differenti- 
ate and then after 3-5 d in culture they die. When cells were 
sampled before this time, it was found that concommitantly 
with this spontaneous initiation of differentiation they began 
to express anion transporter. Furthermore, this was associ- 
ated with an increase in the steady-state levels of the periph- 
eral components. A more careful analysis indicated that the 
cells began to accumulate anion transporter 3-4 d before ces- 
sation of growth and cell death. It is interesting to note that 
normal CFU-E cells go through 3-5  divisions before de- 
veloping into erythrocytes (Till and McCulloch, 1980). AEV 
cells  can  also  be  induced  to  differentiate by  addition  of 
butyrate together with erythropoietin to the cultures. Again 
chemically induced AEV cells accumulated anion transport- 
er and concurrently the steady-state levels of the erythroid- 
specific peripheral components increased. Thus, assuming 
that the pattern of differentiation induced by butyrate does 
not differ from the natural sequence of events, these results 
provide additional evidence that an asynchrony exists in the 
expression of the peripheral components and the anion trans- 
porter during erythropoiesis. 
Overall the results reported here indicate that the differ- 
ences that exist in the steady-state levels of the peripheral 
components of the erythroid membrane skeleton between the 
AEV-transformed erythroid cells and erythroid cells of later 
stages of development are determined by differences in sus- 
ceptibility to catabolism. They further point to a key role for 
the anion transporter in controlling the steady-state levels of 
the peripheral components during terminal differentiation by 
stabilizing assembled molecules from catabolism. However, 
these polypeptides do appear to be competent to assemble 
onto the plasma membrane of transformed cells in the ab- 
sence of anion transporter. By immunofluorescence the spec- 
trins, ankyrin, and protein 4.1 all localize under the plasma 
membrane.  In  addition,  the  solubility  properties,  steady- 
state ratios, and the identical turnover rates for all the eryth- 
roid-specific polypeptides are consistent with the conclusion 
that they are forming a  complex at the membrane but are 
inefficiently cross-linked  into  a  skeletal  array.  Therefore, 
these results further suggest that there must exist additional 
membrane-binding sites other than the anion transporter for 
the  etl3-spectrin/ankyrin/protein 4.1  complex,  albeit  sites 
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tides than the anion transporter. One possibility is that these 
cells are expressing glycophorin,  a transmembrane  protein 
of the mature erythrocyte that has been purported  to bind 
protein 4.1  in human  erythrocytes.  An avian  equivalent of 
glycophorin has not been identified to date, and so this possi- 
bility remains to be tested. 
The issue to be addressed is whether the asynchrony  be- 
tween the expression of the anion transporter and the periph- 
eral constituents of the membrane skeleton reflects the nor- 
mal  sequence  of  events  during  erythropoiesis,  i.e.,  the 
normal phenotype of the CFU-E cells,  or whether it rep- 
resents an anomolous pattern of expression induced by trans- 
formation. Either the site of insertion of the proviruses into 
the chicken genome or the activity of their respective on- 
cogene products could be envisaged to disrupt the normal se- 
quence of expression of erythroid-specific proteins. Since it 
is known that retroviral DNA can integrate  at many sites in 
cellular DNA,  apparently  at random (Hughes et al.,  1978), 
any transformation-specific effect on the expression of eryth- 
roid-specific proteins is most likely to be caused by the activ- 
ity of the oncogene products of AEV and S13. The expression 
of the major oncogene of AEV, v-erb B, has been shown to 
be required for transformation  (Beug et al.,  1982a) and the 
expression of the gp155 protein encoded by the oncogene v-sea 
of the S13 genome has been correlated with transformation 
(Benedict et al.,  1985;  Beug  et al.,  1985).  It has recently 
been demonstrated that gp155 is cleaved posttranslationally 
giving rise to two glycoproteins, gp85 and gp70. The latter 
has been shown to possess tyrosine protein kinase activity 
and so in this regard bears a functional similarity to v-erb B 
gene product (Hayman  et al.,  1985).  However, there is no 
structural homology between v-erb B and v-sea (Benedict et 
al.,  1985).  Until the protein subtrates for these two types of 
tyrosine protein kinases in the transformed  erythroleukemic 
cells  are  identified,  the possibility  exists that this  activity 
may  somehow be anomolously affecting the expression or 
the stability of either the peripheral  components or the anion 
transporter. Alternatively,  it could be argued that these onco- 
genic tyrosine protein kinase activities could just be attenuat- 
ing the normal growth signals of erythroid progenitor cells 
at this stage of differentiation. Thus at present, it appears rea- 
sonable to conclude that the results reported here may reflect 
the normal state of affairs of the stage of erythroid differentia- 
tion these cells are blocked at by these two classes of virus. 
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